FDA approves Given Imaging’s esophagus PillCam

Johnson & Johnson subsidiary Ethicon is due to begin marketing by year-end.

Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) has obtained US Food and Drug Administration (FDA) approval for its esophagus PillCam ESO 2 video capsule for imaging the esophagus.

Given Imaging has granted US marketing rights for the PillCam ESO 2 to Johnson & Johnson (NYSE: JNJ) subsidiary Ethicon Endo-Surgery’s InScope division. Marketing is expected to begin by year-end.

Published by Globes [online], Israel business news - www.globes.co.il - on June 14, 2007

© Copyright of Globes Publisher Itonut (1983) Ltd. 2007

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
Yaron Daniely Replacing Ritalin

Alcobra has had two successful Nasdaq offerings this year as it develops an ADHD treatment with fewer side effects.

Twitter Facebook Linkedin RSS Newsletters